Anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD): a network meta-analysis
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the comparative efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) agents and their biosimilars for people with neovascular age-related macular degeneration (nAMD), and provide a relative ranking of interventions using network meta-analysis (NMA) methods, considering differences in treatment intensity.
Authors
- Robert J. Schillinger
- Sueko M Ng (ORCID: https://orcid.org/0000-0003-2837-8403)
- Geraldine Hoad
- Rosella Saulle
- Ersilia Lucenteforte
Institutions
- Macular Society (GB)
- University of Florence (IT)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1002/14651858.cd016298
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00